Dr Ugur Sahin, CEO, BioNTech, approach to future cancer medicines

Dr Ugur Sahin, CEO of BioNtech, emphasises the need for a polyspecific approach to the treatment of cancer in a panel discussion that followed his Codex Talk at the World's Top 50 Innovators Conference 2019 Dr Ugur Sahin's full Codex Talk can be viewed here    • Individualized Cancer Immunotherapy - Dr U...   His mRNA approach targets multiple mutations simultaneously in advanced cancer. #T50 #BioNTech #Coronavirus #vaccine #covid19 #mRNA#Top50Innovators #CodexTalks #Immunotherapy